Monday, January 22, 2018

News

bobhearing_feat

Bob Twillman Testifies at Senate Hearing for Prescription Drug Abuse

The Academy’s Executive Director Bob Twillman testified at a special Senate Select Committee on Aging hearing held by Senator Claire McCaskill Tuesday in Jefferson City to address the opioid epidemic and the importance of establishing a prescription drug monitoring database in Missouri — the only state in the U.S. without one. He said, “We certainly

clay_njtv

Survey Finds Doctors Prescribed Opioids to Patients, Even After Abuse

The Academy’s Director at Large W. Clay Jackson, MD, DipTh was recently interviewed on NJTV News about how prescription monitoring services don’t include information about overdose. He said, “Around the country we’ve all been working towards an electronic health record, but the trouble with those records is that they often don’t interface or talk well

fda_feat

FDA Approves Naloxone Nasal Spray to Treat Opioid Overdose

On November 18, 2015, the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose. Opioids are a class of drugs that include prescription medications such as oxycodone, hydrocodone, and morphine, as well

Older Posts›› ‹‹Newer Posts